Pharmaust Limited (AU:NUZ) has released an update. Neurizon Therapeutics Limited has reported promising preclinical results for its lead drug ...
Pharmaust Limited (AU:NUZ) has released an update. Neurizon Therapeutics has announced promising preclinical results for its lead drug ...
This is the goal which Neurizon Therapeutics Ltd – the company formerly known as PharmAust – is pursuing through development ...
Stockhead on MSN1h
Scott Power: S&P/ASX 200 Health Care Index falls but which stocks are up on positive news?Morgans healthcare analyst Scott Power notes that while the S&P/ASX 200 Health Care index is down 1.4% over the past ... Read ...
Neurizon Therapeutics Limited (ASX: NUZ & NUZOA) ("Neurizon" or "the Company"), a clinical-stage biotech company advancing treatments for neurodegenerative diseases, is pleased to announce it has ...
MELBOURNE, Australia, Oct. 15, 2024 /PRNewswire/ -- Neurizon Therapeutics Limited (ASX: NUZ) ("Neurizon" or "the Company"), a clinical-stage biotech company dedicated to advancing treatments for ...
14d
Clinical-stage biotech Neurizon Therapeutics – formerly PharmAust – made significant strides advancing its treatments for neurodegenerative diseases during the September 2024 quarter.
Neurizon has been buoyed by the receipt of a positive opinion from the European Medicines Agency in relation to its ...
MELBOURNE, Australia, Oct. 15, 2024 /PRNewswire/ -- Neurizon Therapeutics Limited (ASX: NUZ) ("Neurizon" or "the Company"), a clinical-stage biotech company dedicated to advancing treatments for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback